Extended Ambulatory Monitoring Improves Risk Stratification in Hypertrophic Cardiomyopathy
Status: Unknown
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
Eligible subjects will wear 4 consecutive external monitoring devices for a total of 28 days of monitoring.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• Clinical diagnosis of HCM Scheduled for routine ambulatory monitoring for risk stratification Followed at the Chanin T. Mast HCM Center at Morristown Medical Center
Locations
United States
New Jersey
Morristown Medical Center
Morristown
Time Frame
Start Date: 2016-11
Completion Date: 2018-12-31
Participants
Target number of participants: 83
Treatments
Enrolled subjects
Subjects who are diagnosed with HCM and require routine extended cardiac monitoring for risk stratification of sudden cardiac death. All subjects will receive 28 days of external cardiac monitoring.
Authors
Related Therapeutic Areas
Sponsors
Leads: Atlantic Health System